Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px
Organisation › Details

Carrick Therapeutics Ltd.

Carrick Therapeutics is pioneering a portfolio of unique first-in-class cancer treatments that target driver mechanisms of the most aggressive forms of cancer, and which will be tailored to an individual patient's tumour. Carrick means 'rock' in Irish, the name having been chosen to emphasise the strong foundation of like-minded scientists, collaborators and investors, and the vision to build a world-class company. Carrick has an ambitious patient-focussed vision to serve cancer patients around the world by the introduction of ground-breaking cancer therapies that will transform the way cancer is treated. *


Period Start 2015-01-01 established
  Group Carrick Therapeutics (Group)
Product Industry drug development
Person Person Sullivan, Elaine (Carrick Therapeutics 201501– CEO before Eli Lilly + Evotec 2015H1– Supervisory Board Member)
Region Region Dublin
  Country Ireland, Republic of
  Street Pearse Street
  City Dublin 2
    Address record changed: 2017-09-02
Basic data Employees n. a.
    * Document for �About Section�: Carrick Therapeutics Ltd.. (10/3/16). "Press Release: Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies. $95m Initial Funding from Leading Investor Syndicate". Dublin.
Record changed: 2017-12-07


Picture [iito] – Putting Information into Context 600x102px

More documents for Carrick Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

» top